- •No significant association was present between high BPE and Luminal B, HER2+ or basal subtypes of breast tumor.
- •No significant association between high BPE and axillary nodal disease, high grade tumors, high Ki-67 or larger tumors.
- •Patients with high BPE may be at increased risk for breast cancer but not necessarily for those with a poor prognosis.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Background parenchymal enhancement at breast MR imaging and breast cancer risk.Radiology. 2011; 260: 50-60
- Are qualitative assessments of background parenchymal enhancement, amount of fibroglandular tissue on MR images, and mammographic density associated with breast cancer risk?.Radiology. 2015; 276: 371-380
- Race, breast cancer subtypes, and survival in the Carolina breast cancer study.JAMA. 2006; 295: 2492-2502
- Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.J Clin Oncol. 2008; 26: 2373-2378
Voduc KD, Cheang MC, Tyldesley S, et al. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol;28:1684–1691.
Arvold ND, Taghian AG, Niemierko A, et al. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol;29:3885–3891.
- Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the national comprehensive cancer network.Cancer. 2012; 118: 5463-5472
- Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer.J Clin Oncol. 1994 May; 12: 888-894
- Breast cancer outcome and predictors of outcome: are there age differentials?.J Natl Cancer Inst Monogr. 1994; 16: 35-42
- Young age: an independent risk factor for disease-free survival in women with operable breast cancer.BMC Cancer. 2004 Nov 17; 4: 82
- Is age at diagnosis an independent prognostic factor for survival following breast cancer?.ANZ J Surg. 2005 Sep; 75: 762-767
- Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators.J Natl Cancer Inst. 1994; 86: 1771-1775
- Time-dependence of hazard ratios for prognostic factors in primary breast cancer.Breast Cancer Res Treat. 1998; 52: 227-237
- Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.Br J Cancer. 2007; 96: 1504-1513
- Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry.Breast Cancer Res Treat. 2013; 139: 539-552
- Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.Breast Cancer Res. 2004; 6: R149-56
- Invasive lobular vs ductal breast cancer: a stage-matched comparison of outcomes.Ann Surg Oncol. July 2010; 17: 1862-1869
- Breast cancer prognostic classification in the molecular era: the role of histological grade.Breast Cancer Res. 2010; 12: 207
- Relationship among outcome, stage of disease and histologic grade for 22,616 cases of breast cancer: the basis for a prognostic index.Cancer. 1991 Nov 15; 68: 2142-2149
- Prognostic significance of Nottingham histologic grade in invasive breast carcinoma.J Clin Oncol. 2008 Jul 1; 26: 3153-3158
- Cancer of the breast: size of neoplasm and prognosis.Cancer. 1969; 24: 1071-1080
- Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases.Cancer. 1989; 63: 181-187
- Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.J Natl Cancer Inst. 2009; 101: 736-750
- Lymphatic mapping and sentinel node analysis: current concepts and applications.CA: Cancer J Clin. 2006; 56 ([PubMed Abstract]): 292-309
- Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.Lancet Oncol. 2010; 11 (PubMed Abstract): 927-933
- Pathologic prognostic factors in breast cancer. I. The value of histological grades in breast cancer. Experience from a large study with long-term follow-up.Histopathology. 1991; 19: 403-410
- Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems.Anticancer Res. 1998; 18: 571-576
- WHO classification of tumours of the breast.4th. IARC Press, Lyon2012
- Pathology and genetics of tumours of the breast and female genital organs.IARC Press, Lyon2003
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.Proc Natl Acad Sci U S A. 2001; 98: 10869-10874
- Breast imaging reporting and data system (BI-RADS).5th edition. American College of Radiology, Reston2013
- Inter- and intrareader agreement for categorization of background parenchymal enhancement at baseline and after training.AJR Am J Roentgenol. 2014 Jul; 203: 209-215
- Background parenchymal enhancement at breast MR imaging: normal patterns, diagnostic challenges, and potential for false-positive and false-negative interpretation.Radiographics. 2014 Jan–Feb; 34: 234-247Therapy J Clin Oncol. 2008; 26: 2373-2378
- Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI.Eur Radiol. 2012 Dec; 22: 2641-2647
- The current status of breast MR imaging. I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice.Radiology. 2007; 244: 356-378
- Normal breast parenchyma: contrast enhancement kinetics at dynamic MR mammography—influence of anthropometric measures and menopausal status.Radiology. 2013 Jan; 266: 72-80
- Vascular response of the breast to estrogen.J Clin Endocrinol Metab. 1969; 29: 695-700
- The effect of age and menstrual cycle upon proliferative activity of the normal human breast.Br J Cancer. 1988; 58: 163-170
- Risk for breast cancer development determined by mammographic parenchymal pattern.Cancer. 1976; 37: 2486-2492
- Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study.AJR Am J Roentgenol. 1987; 148: 1087-1092
- Changes in mammographic breast density and concomitant changes in breast cancer risk.Eur J Cancer Prev. 1999; 8: 509-515
- Mammographic features and breast cancer risk: effects with time, age, and menopause status.J Natl Cancer Inst. 1995; 87: 1622-1629
- Reproducibility and consistency in classification of breast parenchymal patterns.AJR Am J Roentgenol. 1983; 140: 1-7
- Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian national breast screening study.J Natl Cancer Inst. 1995 May 3; 87: 670-675
- Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency.Radiology. 1997 Apr; 203: 137-144
- Optimal timing of breast MRI examinations for premenopausal women who do not have a normal menstrual cycle.AJR Am J Roentgenol. 2009; 193: 1738-1740
- Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast.Radiology. 1997; 203: 145-149
☆Work originated from Columbia University Medical Center. No Funding. No Conflict of interest.